Eva Segelov

Eva Segelov is an Adjunct Professor in Medicine at Monash University, affiliated with Monash Health. She specializes in oncology, particularly colorectal and neuroendocrine cancers, and leads numerous international clinical trials, including the ASCOLT and SCOT trials. Her research focuses on personalized medicine, cancer treatment efficacy, and improving patient outcomes. She is a co-founder of CommNETS, an international collaboration for neuroendocrine tumor research, and holds roles in editorial boards, including the Journal of Global Oncology.

Education & Teaching: Segelov has held significant roles at UNSW and St Vincent’s Hospital, contributing to medical education committees, curriculum development, and student supervision. She received awards for teaching excellence, including the Vice Chancellors Award (2006).

Research & Grants: She has secured over $6M in grants, including NHMRC funding for aspirin in colorectal cancer and industry partnerships like the $1.5M CommNETS seed funding. Her work spans drug efficacy studies, biomarkers, and clinical trial design.

Awards & Recognition: Notable honors include the 2016 New Concept Award and Certificates of Outstanding Service in oncology. She has authored over 270 publications and actively contributes to international conferences as a speaker and organizer.

Leadership: Segelov chairs committees in COSA, AGITG, and TROG, overseeing data safety and clinical guidelines. She also leads educational initiatives like preceptorships in colorectal, lung, and prostate cancers.

Community Engagement: She ran the Compassionate Medical Program in the Solomon Islands (2007–2016) and reviews cancer education materials for NSW.